Motus GI Holdings, Inc. announced that it has received approval from the Israeli Ministry of Health, Medical Device Division (known as "AMAR") to initiate commercial sales of the Pure-Vu® EVS System in Israel. The Pure-Vu System EVS integrates with standard and slim colonoscopes, to improve visualization during colonoscopy while preserving established procedural workflow and techniques. Through irrigation and evacuation of debris, the Pure-Vu System is designed to provide better-quality exams. Challenges exist for inpatient colonoscopy and endoscopy, particularly for patients who are elderly, with comorbidities, or active bleeds, where the ability to visualize, diagnose and treat is often compromised due to debris, including fecal matter, blood, or blood clots.

Motus GI believes this is especially true in high acuity patients, like upper GI bleeds where the existence of blood and blood clots can impair a physician?s view and removing them can be critical in allowing a physician the ability to identify and treat the source of bleeding on a timely basis. Patients struggling to get a high-quality prep prior to their colonoscopy can lead to delayed, aborted and repeat procedures, which puts a burden on the healthcare system and the patient, both from a clinical and economic perspective. According to the literature, early repeat exams happen between 10% and 20% of the time in outpatient colonoscopies and many patients don't come back as prescribed, which leaves them at a higher risk for an interval cancer, especially for patients at high risk for CRC.

The Pure-Vu EVS is already cleared by the U.S. Food and Drug Administration (FDA) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy.